Minecraft is entering a new era in 2026. With the launch of Minecraft Java 26.1, Mojang is not just releasing another content patch — it’s introducing a new yearly versioning system and laying down ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

The first season of HBO's It: Welcome to Derry has come to a close, leaving us with a long list of questions that need to somehow be answered when the show leaps back in time another 27 years for ...

Warning: this article contains full spoilers for Andor Season 2’s finale. If you haven’t already, be sure to check out IGN's review for Andor Season 2, Episodes 10-12. Andor Season 2 just wrapped on ...

Wicked: For Good concludes the tale of doomed friendship between Elphaba (Cynthia Erivo) and Glinda (Ariana Grande), turning to a new page in the Grimmerie as the story ends. The film is an ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

SPOILER ALERT: This story contains spoilers for the first two episodes of “Pluribus,” streaming now on Apple TV. Not only did “Breaking Bad” earn four more seasons that cemented it as one of the ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.